Company intelligence / Profile preview

Goodwill Pharma

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Goodwill Pharma has a strong commercial presence in Central and Eastern Europe with an extensive product portfolio of pharmaceuticals and nutraceuticals. Notable products include Makula Complex for macular degeneration and Wiloxon for thyroid health. The company operates under EU-GMP standards with FDA registration for its plant. It offers contract manufacturing services alongside its own branded lines. No clinical trial results are specifically highlighted.

Therapeutic areas: EndocrinologyOphthalmologyNephrologyInfectious Diseases
Modalities: Small molecules (Rx and OTC medicines)dietary supplements/nutraceuticalsmedical devices
Industry: Food & Nutrition

Partnerships

Several local/global partners across Central/Eastern Europe but no specific major pharma partnerships named publicly. Offers CMO/CDMO services to industry clients.

Beyond the preview

Go deeper on Goodwill Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goodwill Pharma.

Explore the full profile